A Holiday Message from Dean Sam Poloyac

A man smiling.
December 4, 2020
Watch and read a special video holiday message from UT College of Pharmacy Dean Samuel M. Poloyac.

Williams Wants to Turn COVID-19 Vaccine into Powder to Help with Storage and Distribution

A powder in a vial.
November 25, 2020
Molecular Pharmaceutics and Drug Delivery Professor Robert O. (Bill) Williams III, Ph.D. talks to CBS Austin about the potential for his thin film freezing technology to increase the shelf life of COVID-19 vaccines when they become available.

In Remembrance of Dr. Ted Mills

A man wearing a suit and tie.
October 23, 2020
It is with great sadness that we announce the passing of Edward (Ted) Mills, Ph.D., associate professor in the Division of Pharmacology and Toxicology and Bergen Brunswig Corporation Centennial Fellow.

H-E-B Opens New Pharmacy on UT Austin Campus

Two men holding mugs and talking.
October 21, 2020
“H-E-B has been an innovator in community pharmacy practice in Texas. The UT College of Pharmacy has a long history of collaboration with H-E-B, including training the next generation of pharmacists through internships, experiential rotations, and post-graduate residencies,” said Dean Samuel M. Poloyac. “The opening of the new pharmacy on the UT Austin campus is a wonderful opportunity to enhance our partnership. We are excited to work together on this new endeavor.”

A Message from Dr. Sam Poloyac on His First Day as Dean

A man smiling.
October 15, 2020
Samuel M. Poloyac, Pharm.D., Ph.D. addresses the community on his first day as dean of The University of Texas at Austin College of Pharmacy.

Inhaled Niclosamide a Potential Effective Antiviral to Treat COVID-19

An infrared image of nasal spray being administered.
September 29, 2020
Researchers in the lab of Dr. Hugh D.C. Smyth have released promising results of a new method to treat SARS-CoV-2, the coronavirus that causes COVID-19. The antiviral niclosamide, when incorporated with human lysozyme as a carrier molecule, shows potential as an effective COVID-19 treatment when delivered directly to the airways.

Live Subject Testing Shows Promising Delivery Method for COVID-19 Antiviral Treatment

A microscopic image.
September 23, 2020
Live subject testing results from the Williams Lab show that dry powder inhalation could be a potent and effective delivery method of the antiviral remdesivir to treat patients affected by COVID-19.

Richburg Receives NIH Grant Award for Toxicant Injury Research

A man smiling
August 10, 2020
Associate Dean for Research and Graduate Studies John H. Richburg, Ph.D. received notice from the National Institutes of Health (NIH) awarding him a research grant for a five-year term. The NIH’s grant award for Dr. Richburg’s research totals $2,694,316.

UT 3D Printing Labs Enter Patent License Agreement to Develop Digital 3D Drug Manufacturing and Advanced Drug Delivery Systems

Patient-centric 3D printing paradigm of medicines at the point-of-care.
July 17, 2020
Assistant Professor Mo Maniruzzaman’s Pharmaceutical Engineering and 3D Printing (PharmE3D) labs have entered an agreement with UK-based CoM3D to develop digital 3D drug manufacturing and advanced drug delivery systems.

Maniruzzaman Lab Collaboration Works to Develop Patient-Focused Medicines More Efficiently

mo lab 3d printer
April 27, 2020
To meet the need to develop methods to make drugs more soluble and usable, the Maniruzzaman Lab teamed up with Advanced Material Development (AMD) to address challenges with the reduction in quantity of new drugs coming to market.